FDA ruling 21 CFR Part 11 specifies how electronic records and electronic signatures can be used as a substitute for paper records and handwritten signatures. It is broadly applicable to electronic records, including temperature measurement.
Cloud computing is beginning to have an impact on the conduct of clinical trials, healthcare compliance, and storage of pharmaceuticals. Increasing regulatory pressures, and the need to reduce cost, automated “cloud monitoring” has become a viable option for Hospitals with a need to focus on their core competencies.
Recent amendments to CDC guidance have included a recommendation to utilize at least one back-up device at each Location where vaccines and/or similar inventory are being monitored.
This document describes the use of a PharmaWatch™ SNEXT sensor with a display to accommodate this recommendation.
The Auto Recalibration Program will provide notification 30 days prior to the expiration date of your NIST certificate(s), then deliver new calibrated replaceable probes that can be quickly switched out to maintain continuous compliance with a minimum of fuss on your part. NIST certificates are automatically and always available via this process and can be downloaded anytime from the PharmaWatch™ Portal with a single click.
American Pharma is pleased to release PharmaWatch™ 3.4! This update includes work to accelerate access and
American Pharma is pleased to release PharmaWatch™ 3.3! This release includes a number of new features
American Pharma is pleased to release PharmaWatch™ 3.2! This release includes a number of new features
American Pharma is pleased to release PharmaWatch™ 3.1! This release includes a number of new features
American Pharma is pleased to release PharmaWatch™ 3.0! This release includes a number of new features
American Pharma is pleased to release PharmaWatch™ 2.9! This release includes a number of new features
Fill out the information below to start your FREE demo.
